Kory Wentworth
Director Financiero/CFO en ENTRADA THERAPEUTICS, INC. .
Fortuna: 219 884 $ al 30/04/2024
Cargos activos de Kory Wentworth
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director Financiero/CFO | 01/11/2020 | - |
| Treasurer | 01/11/2020 | - |
Historial de carrera de Kory Wentworth
Antiguos cargos conocidos de Kory Wentworth.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 18/12/2017 | 08/09/2020 |
| Treasurer | 18/12/2017 | 02/10/2020 | |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/11/2017 | 01/12/2017 |
| Director/Miembro de la Junta | 01/01/2012 | 01/12/2017 | |
| Corporate Officer/Principal | 01/12/2008 | 01/12/2017 |
Formación de Kory Wentworth.
| Susquehanna University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Kory Wentworth
- Experiencia
